Regulatory Affairs Journal

Founded in 1990, The Regulatory Affairs Journal (RAJ) has established an international reputation as the primary source of regulatory intelligence, news and opinion for the pharmaceutical industry and regulatory agencies, worldwide.

Twelve monthly issues
Global coverage
Overview and comments by experts

View Examples View current contents Subscribe

The RAJ archives from 1992 are also available on the fully indexed and searchable RAJ CD ROM

Each Issue of RAJ gives you:

Features and Editorials: in depth reviews and discussions of current regulatory issues and developments

Worldwide Update: information on changes in regulatory requirements not only in the major markets of the industrialised world but also in those parts of the world where information is often hard to obtain

Reference information: organisation charts and contact lists for regulatory authorities in all parts of the world, summary charts of key legislation and guidelines etc., etc.

Examples from The Regulatory Affairs Journal
The Regulatory Affairs Journal is well known for the clarity with which complex regulatory information is organised and provided, with tabulated data, references and helpful margin notes to act as a guide. Don't take our word for it, however - look at some examples:

Feature: June 2000: Compassionate Use and Early Access to the Market in the USA and EU (Part 1)
In a feature article, Elisabeth Bourg and Fran�oise de Cr�miers reviewed the current situation in the USA for compassionate use and early access to the market for medicinal products intended to treat life-threatening diseases.

Worldwide Update:
Developments in the European Union provided each month: Example.
Updates on new FDA documents and requirements: Example.
Other major markets covered in detail: Example.
Information from WHO and from those not-so easy to monitor regions: Example.

Reference
Tabulated quick-reference charts of recent legislation and guidelines: Example.

Reprints
BSE/TSE Risks
by Brian R. Matthews, B. Pharm, PhD, MRPharmS, MBIRA

Look at the contents of the current issue.